Applied Biosystems, Celera Genomics, GeneOhm, Sciona Ltd., Tm Bioscience, Variagenics deal

VGNX granted Celera Diagnostics, a joint venture between CRA and ABI, non-exclusive worldwide rights to VGNX's methylenetetrahydrofolate reductase (MTHFR) IP to develop products that detect MTHFR poly...